{
    "2021-12-02": [
        [
            {
                "time": "2021-11-18",
                "original_text": "抗 癌 新 药 闯 关 失 败 恒 瑞 医 药 遇 挫 万 春",
                "features": {
                    "keywords": [
                        "抗癌新药",
                        "恒瑞医药",
                        "万春",
                        "失败"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-20",
                "original_text": "投 资 新 药 上 市 申 请 遭 F D A 拒 绝！3 0 0 0 亿 市 值 医 药 龙 头 回 应：尚 未 进 行 股 权 交 割",
                "features": {
                    "keywords": [
                        "FDA",
                        "拒绝",
                        "恒瑞医药",
                        "新药上市",
                        "股权交割"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-22",
                "original_text": "F D A 打 击 了 万 春 药 业，却 擦 伤 了 恒 瑞？",
                "features": {
                    "keywords": [
                        "FDA",
                        "万春药业",
                        "恒瑞",
                        "打击"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-25",
                "original_text": "万 春 医 药 新 药 上 市 遭 拒，恒 瑞 再 受 牵 连，新 药 研 发 会 是 “ 不 归 路 ” 吗？",
                "features": {
                    "keywords": [
                        "万春医药",
                        "新药上市",
                        "遭拒",
                        "恒瑞",
                        "牵连"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-01",
                "original_text": "上 交 所 发 监 督 函，恒 瑞 研 发 费 用 资 本 化 始 末",
                "features": {
                    "keywords": [
                        "上交所",
                        "监督函",
                        "恒瑞",
                        "研发费用",
                        "资本化"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-12-05",
                "original_text": "人 民 金 融 · 创 新 药 指 数 涨 1 . 1 8 % | 又 有 三 款 中 药 创 新 药 获 批，中 药 改 革 见 成 效",
                "features": {
                    "keywords": [
                        "创新药指数",
                        "上涨",
                        "中药",
                        "获批",
                        "改革成效"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-12-10",
                "original_text": "F D A 拒 绝 批 准 普 那 布 林 上 市 万 春 药 业 暴 跌 6 0 % 恒 瑞 微 跌 1 . 9 2 %",
                "features": {
                    "keywords": [
                        "FDA",
                        "普那布林",
                        "拒绝",
                        "万春药业",
                        "暴跌",
                        "恒瑞",
                        "微跌"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}